Recomienda este artículo a tus amigos:
Resistance to Targeted Therapies in Breast Cancer - Resistance to Targeted Anti-Cancer Therapeutics Softcover Reprint of the Original 1st 2017 edition
Resistance to Targeted Therapies in Breast Cancer - Resistance to Targeted Anti-Cancer Therapeutics
We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast cancer (i.e., EGFR and Wnt signaling).
184 pages, 12 Illustrations, black and white; XV, 184 p. 12 illus.
| Medios de comunicación | Libros Paperback Book (Libro con tapa blanda y lomo encolado) |
| Publicado | 23 de junio de 2018 |
| ISBN13 | 9783319888910 |
| Editores | Springer International Publishing AG |
| Páginas | 184 |
| Dimensiones | 150 × 220 × 10 mm · 290 g |
| Lengua | Alemán |
| Editor | Prosperi, Jenifer R. |